Clinical Development business of Laboratory Corporation of America Holdings (FTREV) shares gained 3.91% today (2023-06-22). Is it the right time to buy?

What’s happening at Clinical Development business of Laboratory Corporation of America Holdings (NasdaqGS:FTREV)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 3.91% (or 1.25 points) to $33.25 from its previous close of $32.00. So
Read more: Clinical Development business of Laboratory Corporation of America Holdings (FTREV) shares gained 3.91% today (2023-06-22). Is it the right time to buy?